Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH

PHASE3CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

September 30, 2014

Study Completion Date

December 31, 2014

Conditions
Heart Failure, DiastolicPulmonary Hypertension
Interventions
DRUG

Sildenafil

Sildenafil administered orally 3 times per day 20 mg for the first 2 weeks, followed by 3 times 60 mg for 10 weeks

DRUG

Placebo

Placebo tablets 3 times per day 20 mg foor de first 2 weeks, followed by 3 times 60 mg for 10 weeks

Trial Locations (1)

9700 RB

University Medical Center Groningen, Groningen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University Medical Center Groningen

OTHER

NCT01726049 - Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH | Biotech Hunter | Biotech Hunter